NEPH vs USB · P/E 48, rev $14.2M vs P/E 12, rev $28.66B
Nephros Inc (NEPH) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the NEPH and USB stock pages for the full models.
Not investment advice.